ImmunoPET imaging of renal cell carcinoma with 124I-and 89Zr-labeled anti-CAIX monoclonal antibody cG250

被引:0
|
作者
Stillebroer, Alexander [1 ]
Franssen, Gerben [1 ]
Oyen, Wim [1 ]
Oosterwijk, Egbert [2 ]
Laverman, Peter [1 ]
Mulders, Peter [2 ]
Boerman, Otto [1 ]
机构
[1] Radboud Univ Nijmegen, Nucl Med, Med Ctr, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Urol, Med Ctr, Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
500
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Optimization of radioimmunotherapy of renal cell carcinoma:: Labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re
    Brouwers, AH
    van Eerd, JEM
    Frielink, C
    Oosterwijk, E
    Oyen, WJG
    Corstens, FHM
    Boerman, OC
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (02) : 327 - 337
  • [32] PET/CT imaging of clear cell renal cell carcinoma with I-124 labeled chimeric antibody
    Bahnson, Eamonn E.
    Murrey, Douglas A., Jr.
    Mojzisik, Cathy M.
    Hall, Nathan C.
    Martinez-Suarez, Humberto J.
    Knopp, Michael V.
    Martin, Edward W., Jr.
    Povoski, Stephen P.
    Bahnson, Robert R.
    THERAPEUTIC ADVANCES IN UROLOGY, 2009, 1 (02) : 67 - 70
  • [33] A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients (pts) with advanced renal cell carcinoma (RCC).
    Davis, ID
    Liu, Z
    Saunders, W
    Lee, FT
    Spirkoska, V
    Hopkins, W
    Smyth, F
    Hoffman, EW
    Old, LJ
    Scott, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 177S - 177S
  • [34] A Prospective Open-label Single-Arm Phase II Study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patients
    Varga, Z
    de Mulder, P
    Kruit, W
    Hegele, A
    Hofmann, R
    Lamers, C
    Warnaar, S
    Mala, C
    Ullrich, S
    Mulders, P
    FOLIA BIOLOGICA, 2003, 49 (02) : 74 - 77
  • [35] LUD01-014: Phase 1/2 study of chimeric monoclonal antibody cG250 in combination with vinblastine in patients with advanced renal cell carcinoma (ARCC).
    Al-Batran, SE
    Neumann, A
    Atmaca, A
    Ruppert, M
    Karbach, J
    Ritter, G
    Hoffman, E
    Old, L
    Knuth, A
    Jaeger, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 170S - 170S
  • [36] Comparison of 131I-CG250 monoclonal antibody immunoscintigraphy (RIS) and FDG-PET imaging in patients with metastatic renal cell carcinoma (RCC).
    Brouwers, AH
    Dörr, U
    Bihl, H
    Steffens, MG
    Oyen, WJ
    Boerman, OC
    Oosterwijk, E
    Corstens, FH
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 117P - 117P
  • [37] Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250
    Steffens, MG
    Boerman, OC
    de Mulder, PHM
    Oyen, WJG
    Buijs, WCAM
    Witjes, JA
    van den Broek, WJM
    Oosterwijk-Wakka, JC
    Debruyne, FMJ
    Corstens, FHM
    Oosterwijk, E
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3268S - 3274S
  • [38] Radioimmunotargeting with I-131 labeled chimeric G250 monoclonal antibody in patients with renal cell carcinoma.
    Steffens, MG
    Boerman, OC
    Oosterwijk, E
    Oosterhof, GON
    Witjes, JA
    OosterwijkWakka, JC
    Koenders, E
    Debruyne, FMJ
    Corstens, FHM
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 740 - 740
  • [39] SCINTIGRAPHY OF RENAL-CELL CARCINOMA WITH I-131-LABELED MONOCLONAL-ANTIBODY (MAB) G250
    DIVGI, CR
    OOSTERWIJK, E
    SCOTT, AM
    BANDER, N
    OOSTERWIJK, J
    WELT, S
    LARSON, SM
    OLD, LJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 576 - 576
  • [40] Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses:: a phase I trial
    Divgi, Chaitanya R.
    Pandit-Taskar, Neeta
    Jungbluth, Achim A.
    Reuter, Victor E.
    Gonen, Mithat
    Ruan, Shutian
    Pierre, Christine
    Nagel, Andrew
    Pryma, Daniel A.
    Humm, John
    Larson, Steven M.
    Old, Lloyd J.
    Russo, Paul
    LANCET ONCOLOGY, 2007, 8 (04): : 304 - 310